Author:
Pérez-Matute Patricia,Pérez-Martínez Laura,Blanco José Ramón,Oteo José Antonio
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference41 articles.
1. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors;Carr;Aids,1998
2. Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients;Stanley;Aids,2009
3. Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir;Haerter;Aids,2004
4. Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1;Katlama;Aids,2007
5. Aberg J, Overton T, Gupta S, Falcon R, Ryan R, De La Rosa G, METABOLIK (metabolic evaluation in treatment-naives assessing the impact of two boosted protease inhibitors on lipids and other markers): comparison of the metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir over 12 weeks, in XVIII International AIDS Conference. Vienna, 2010.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献